Ratings by Roth Capital (Jonathan Aschoff)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/11/2021 Novan NOVN Maintain Buy
(N/A)
 
 
  Details
6/3/2021 Vascular Biogenics Ltd VBLT Maintain Neutral
(N/A)
 
 
  Details
5/17/2021 Seelos Therapeutics SEEL Downgrade Neutral
(Buy)
5.19
(3.39)
-34.68% Details
4/22/2021 Novan NOVN New Coverage Buy
()
1.17
(17.35)
1382.91% Details
4/1/2021 AzurRx Biopharma AZRX Maintain Buy
(N/A)
 
 
  Details
3/11/2021 Shoals Technologies Group SHLS New Coverage Buy
(N/A)
35.85
(30.66)
-14.48% Details
3/4/2021 TFF Parmaceuticals TFFP Maintain Buy
(N/A)
 
 
  Details
2/12/2021 Applied DNA Sciences APDN New Coverage Buy
(N/A)
12.57
(6.74)
-46.38% Details
2/1/2021 Moleculin Biotech MBRX Maintain Buy
(N/A)
 
 
  Details
1/25/2021 Kempharm KMPH New Coverage Buy
(N/A)
6.02
(14.40)
139.2% Details
12/7/2020 Acer Therapeutics ACER Maintain Buy
(N/A)
 
 
  Details
11/17/2020 Inovio Pharmaceuticals INO Downgrade Sell
(Neutral)
12.85
(8.91)
-30.66% Details
11/10/2020 Inovio Pharmaceuticals INO Upgrade Neutral
(Sell)
10.53
(12.85)
22.03% Details
11/9/2020 Aptevo Therapeutics APVO Maintain Buy
(N/A)
 
 
  Details
11/6/2020 Entasis Therapeutics ETTX Maintain Buy
(N/A)
 
 
  Details
10/15/2020 TFF Parmaceuticals TFFP Maintain Buy
(N/A)
 
 
  Details
9/28/2020 Inovio Pharmaceuticals INO Maintain Sell
(N/A)
 
 
  Details
8/14/2020 TFF Parmaceuticals TFFP Maintain Buy
(N/A)
 
 
  Details
8/11/2020 Inovio Pharmaceuticals INO Maintain Sell
(N/A)
 
 
  Details
7/14/2020 INmune Bio Inc. INMB Maintain Buy
(N/A)
 
 
  Details
7/13/2020 Entasis Therapeutics ETTX New Coverage Buy
(N/A)
2.94
(3.04)
3.4% Details
7/1/2020 Inovio Pharmaceuticals INO Downgrade Sell
(Neutral)
26.95
(8.91)
-66.94% Details
6/29/2020 Acer Therapeutics ACER New Coverage Buy
(N/A)
3.52
(3.05)
-13.35% Details
5/14/2020 Eyenovia EYEN Maintain Buy
(N/A)
 
 
  Details
5/12/2020 Inovio Pharmaceuticals INO Maintain Neutral
(N/A)
 
 
  Details
4/30/2020 Inovio Pharmaceuticals INO Downgrade Neutral
(Buy)
13.74
(8.91)
-35.15% Details
4/27/2020 Cyclacel Pharmaceuticals CYCC New Coverage Buy
(N/A)
4.02
(7.05)
75.37% Details
3/4/2020 Aptevo Therapeutics APVO New Coverage Buy
(N/A)
0.39
(28.08)
7100% Details
2/19/2020 Aridis Pharmaceuticals ARDS New Coverage Buy
(N/A)
6.15
(7.03)
14.31% Details
1/27/2020 Eyenovia EYEN New Coverage Buy
(N/A)
4.21
(5.45)
29.45% Details
1/24/2020 AzurRx Biopharma AZRX New Coverage Buy
(N/A)
1.08
(0.87)
-19.44% Details
12/19/2019 Inovio Pharmaceuticals INO New Coverage Buy
(N/A)
2.63
(13.74)
422.43% Details
12/19/2019 INmune Bio Inc. INMB New Coverage Buy
(N/A)
5.72
(18.64)
225.87% Details
12/19/2019 Ampio Pharmaceuticals AMPE New Coverage Buy
(N/A)
0.41
(1.80)
339.02% Details